Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectivesOA
Toward the precision use of Chinese PARP inhibitors in ovarian cancer:clinical progress,resistance mechanisms,and future perspectives
Jing Yu;Maochen Li;Yuhan Zhu;Shengnan Wang;Yuzhao Jiang;Wei Cui;Lingying Wu
Department of Clinical Laboratory,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China||Department of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaInstitute of Basic Medical Sciences,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100005,ChinaDepartment of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Clinical Laboratory,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Clinical Laboratory,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,ChinaDepartment of Gynecologic Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
《癌症生物学与医学（英文版）》 2026 (6)
788-795,8
This work was supported by grants from the CAMS Innovation Fund for Medical Sciences[CIFMS](Grant No.2025-12M-KJ-004)and the National Natural Science Foundation of China(Grant No.81772272).
评论